Hepatocellular carcinoma (HCC) is the most regular type of basic liver cancer. This type of cancer occurs more repeatedly in men than women. It is usually diagnosed in people age 48 or older. Hepatocellular carcinoma also occurs mostly in people with chronic liver diseases, like cirrhosis caused by hepatitis B or hepatitis C infection. Liver injury caused by viral factor affects many biological processes such as apoptosis, transcription, cell signaling, DNA repair which can also produce important effects on cell growth, survival and maintenance. Continued improvement in both surgical and nonsurgical approaches has demonstrated significant benefits in overall survival. While OLT remains the only therapeutic surgical procedure, the deficiency of available organs excludes this therapy for many patients with HCC. People with hepatitis B or C are at huge risk of liver cancer, even if they do not promote cirrhosis.
Review Article: Hepatology and Pancreatic Science
Review Article: Hepatology and Pancreatic Science
Short Communication: Hepatology and Pancreatic Science
Short Communication: Hepatology and Pancreatic Science
Research Article: Hepatology and Pancreatic Science
Research Article: Hepatology and Pancreatic Science
Case Report: Hepatology and Pancreatic Science
Case Report: Hepatology and Pancreatic Science
Case Report: Hepatology and Pancreatic Science
Case Report: Hepatology and Pancreatic Science
Posters & Accepted Abstracts: Pulmonary & Respiratory Medicine
Posters & Accepted Abstracts: Pulmonary & Respiratory Medicine
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Journal of Forensic Research
Scientific Tracks Abstracts: Journal of Forensic Research
Hepatology and Pancreatic Science received 34 citations as per Google Scholar report